Discontinued — last reported Q4 '17
Non-Current Assets
Indefinite-Lived Research and Development Assets
Robinhood Markets, Inc. Indefinite-Lived Research and Development Assets increased by 139.4% to $79.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1480.0%, from $5.00M to $79.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2017
How to read this metric
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
Detailed definition
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Peer comparison
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
Metric ID:
indefinite_lived_rd_assetsHistorical Data
6 periods
| Q3 '21 | Q3 '23 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $1.65M | $2.00M | $5.00M | $44.00M | $33.00M | $79.00M |
| QoQ Change | — | +21.1% | +150.0% | +780.0% | -25.0% | +139.4% |
| YoY Change | — | — | — | — | — | >999% |
Range$1.65M – $79.00M
CAGR>999%
Avg YoY Growth>999%
Median YoY Growth>999%
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Robinhood Markets, Inc.'s indefinite-lived research and development assets?
- Robinhood Markets, Inc. (HOOD) reported indefinite-lived research and development assets of $79.00M in Q1 2026.
- How has Robinhood Markets, Inc.'s indefinite-lived research and development assets changed year-over-year?
- Robinhood Markets, Inc.'s indefinite-lived research and development assets increased by 1480.0% year-over-year, from $5.00M to $79.00M.
- What does indefinite-lived research and development assets mean?
- The value of ongoing research projects acquired from other companies that are not yet ready for sale.